19.02.2020
- Sanofi Pasteur, the vaccines global business unit of French drugmaker Sanofi, plans to work with the Biomedical Advanced Research and Development Authority (BARDA), part of the US...
13.02.2020
- Paul Hudson, new CEO of Sanofi, has taken quick steps to implement a plan announced on Feb. 6 to reduce the company's executive committee from 14 to 10 members. At the company’s Q4...
27.01.2020
- Sanofi has completed its acquisition of US biotech Synthorx as planned for $68 per share in cash. This follows expiration of the French pharma giant’s tender offer for all of the...
10.12.2019
- French drugmaker Sanofi has signed a definitive agreement to buy Synthorx, a US clinical-stage US biotech focused on cancer and autoimmune disorders, for $68 per share. The cash...
07.11.2019
- French drugmaker Sanofi has paid $315 million to investors to settle claims it dragged its feet on advancing the development of multiple sclerosis drug Lemtrada, which it acquired...
19.09.2019
- French drugmaker Sanofi and US pharma and medical devices company Abbott Laboratories have teamed up to integrate glucose sensing and insulin delivery technologies, with the aim of...
09.09.2019
- The Together for Sustainability (TFS) initiative was launched in 2011 as a joint program of chemical companies for sustainable supply chains. Its goal is to develop and implement a...
25.07.2019
- Under an exclusive deal with Roche, French drugmaker Sanofi has secured non-prescription rights to the Swiss pharmaceutical giant’s now off-patent influenza drug Tamiflu in the US...
